Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: A diagnosis on the health of the economy

It has been a bit of a stalemate for North American markets this week as indices nudged one way or another. Earnings report have been rolling in, with some major U.S. banks reporting a slowdown in profits, others saw better-than-expected earnings. Traders are tracking an ...
Jonathon Brown | April 20, 2023 |

Fed Slashes Rates to Zero and Introduces QE in Response to COVID-19. Will Gold Rally Now?

On Sunday, the Federal Reserve cut interest rates and restarted quantitative easing to stimulate economy hit by the pandemic of COVID-19. That’s already its second move prior to this Wednesday’s FOMC. What does it imply for gold? It&CloseCurl...
Arkadiusz Sieron | March 16, 2020 |

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

Growth Is Crushing Value Right Now, but Take a Long-Term Horizon

Investors are betting on growth stocks over value stocks by a wider spread right now than at any other time since at least 1990, including during the tech bubble. The ratio between the Russell 1000 Growth Index and Russell 1000 Value Index reached a series high of 1....
Frank Holmes | May 27, 2020 |

With Contact Tracing Key to Reopening the Economy, New Cloud Platform Attracting High-Profile Users

As contact tracing moves to center stage as a key to reopening the economy, HealthSpace releases a scalable cloud-based system that is rapidly being adopted, including by the state of Hawaii. HealthSpace Data Systems Ltd. (HS:CSE; HSDLF:OTCMKTS) , a Software...
Streetwise Reports | April 29, 2020 |

Coronavirus Propels Telemedicine into the Spotlight

Summary: Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the '90s but had failed to catch on. Now, a concerted effort by healthcare providers, insurance companies, the federal government...
Streetwise Reports | March 27, 2020 |

Will the Fed Going Nuclear Help the Economy and Gold?

On Monday, the Fed introduced QE-infinity. What does it imply for the US economy and the gold market? Fed Drops Bazooka… and Goes Nuclear Instead! On Monday, the Fed pulled out an even larger bazooka than it did previously. Or, forget about the bazooka. The US c...
Arkadiusz Sieron | March 26, 2020 |

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs

Shares of Moderna Inc. traded up double-digits today as the firm announced results from its Phase 1 CMV Vaccine Study as well as its Phase 1 data for mRNA-1944 encoding for antibody against the chikungunya virus. This morning clinical-stage biotechnology company Mode...
Streetwise Reports | September 13, 2019 |

Valeo Pharma bringing to market drug undergoing clinical trials to improve survival of COVID-19

Valeo Pharma Inc. (CSE: VPH) is a fast-growing revenue generating specialty pharmaceutical company with a strong product portfolio and a robust product pipeline. Valeo Pharma Inc. (CSE: VPH) is a fully integrated specialty pharmaceutical company focused on in-lice...
James O'Rourke | May 22, 2020 |

Covid-19: Who, what, when, where and why

If there is one thing we know about the coronavirus, it’s that getting a jump on it helps to limit the number of infections. Clearly the best time to stop this, and all outbreaks, is in its early stages. Both China and the United States have been accused of...
Richard (Rick) Mills | April 13, 2020 |
1 2 3 4 5 6 7 8 9 10 ...